Catalyst Wire Dossier Catalyst Wire Dossier

lonapegsomatropin

lonapegsomatropin · Ascendis Pharma
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for lonapegsomatropin, covering 2025-01-15 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia [Phase 2]

See pricing